Tioga Research is excited to announce that it has been named a Scrip Award finalist in the Best CRO – Specialist Providers category. The Scrip Award highlights the highest achievers of innovation in the biotechnology and pharmaceutical industries. For more information, please click on the link below. https://pharmaintelligence.informa.com/events/awards/scrip-awards-2018/shortlist Tioga Research
Read MoreMonth: September 2018
Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies
Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies GB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease SWINDON, U.K., and LAS VEGAS, September 26, 2018– GB Sciences, Inc. (OTCQB: GBLX) and Catalent Pharma Solutions, the […]
Read MoreTioga Research at the first Annual San Diego Futures Foundation STEMFEST. They had the opportunity to educate the community on skin permeation and various forms of skin applied formulations.
Ashley and Holly represented Tioga Research at the first Annual San Diego Futures Foundation STEMFEST. They had the opportunity to educate the community on skin permeation and various forms of skin applied formulations. Tioga Research
Read MoreAucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form
Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form Catalent Somerset, N.J. – September 4, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a commercial supply agreement for Aucta Pharmaceuticals, Inc.’s (Aucta) vigabatrin. […]
Read More